Latest News on Big Pharma
Showing of 0 - 10 from 15 results
Big Pharma - Total results - 15
Jul 31, 2018
GSK to access DNA data from millions by partnering with Google-funded 23andMeWith more than 5 million customers, 23andMe has a trove of information about the links between genes and disease.
Dec 26, 2017
Clinical testing of drugs on dogs is a cruel practice, doesn't add value or provide data that is applicable to humansThe primary objection to the specific use of dogs in testing is thus simple — the data derived from dogs is not predictive enough to be applied to the case of humans
Jun 07, 2016
Why Narendra Modi’s US visits make the sick and poor in India anxiousThe fear is that if Narendra Modi capitulates to US pressure on India’s Intellectual Property Rights (IPR) regime, which it has been overtly and covertly exerting for years, it will make many lifesaving drugs unaffordable
Feb 04, 2014
World Cancer Day: Debate on affordable drugs must focus on life or death for millionsOn World Cancer Day, here is arithmetic to show that big pharma's justification for high prices of life-saving drugs is not the complete truth.
Aug 07, 2013
Breast cancer drugs: Is UPA succumbing to US pharma pressure?There has been a systematic effort by the western media, international business bodies and their trade proxies to malign India. Perhaps the biggest pressure came from the US, both by the government and trade and business organisations.
Aug 02, 2013
India revokes GSK patent on breast cancer drug TykerbIndia's patent appeals board has revoked a patent granted to GlaxoSmithKline Plc's breast cancer drug Tykerb, which is a salt form of the original compound, lapatinib.
Jun 10, 2013
How Big Pharma-designed cacophony against Ranbaxy drowns vital voicesIn the unresisted and rapidly rising cacophony against the FDA-tainted Ranbaxy, what get drowned unfortunately are voices that are vital to the country's drug industry and people's health.
May 30, 2013
Ranbaxy debacle: Big Pharma's target is Indian drug industryIt's abundantly clear that the Ranbaxy fiasco in the US, in which the company has to pay $500 million for allegedly selling adulterated drugs, is the big opportunity that the multinational drug companies have been waiting for to malign India.
Apr 10, 2013
India-EU FTA will imperil lives, local industry, say activistsHolding placards that said: "EU FTA kills patients", "FTA kills domestic production of medicine" about 250 people gathered at Jantar Mantar this afternoon urging the government to not sign the Free Trade Agreement with the European Union
Apr 05, 2013
HC denies interim relief to Merck in patent case against GlenmarkThe interim application of the multinational pharma major that Glenmark be restrained from manufacturing and selling the anti-diabetes medicines on the grounds that the salt used in the drugs were not of generic nature was denied by the court.